Pharmacovigilance India 2022 - Register now in early bird and save INR 5,000

29th Pharmacovigilance India 2022

10th November 2022, Hotel Kohinoor Continental, Mumbai, India

We are happy to invite you to attend our 29th Pharmacovigilance India 2022 conference to be held on 10th November 2022 at Hotel Kohinoor Continental, Mumbai, India.

Link to download event brochure, conference webpage and to register online -

https://virtueinsight.com/event/pharmacovigilance-india/

KEY SPEAKERS INCLUDE

K BANGARURAJAN, Adviser, CDSCO (New Delhi)
SAKSHI SHRIVASTAVA DESAI, Associate Director International, Pharmacovigilance Strategy Realization, Johnson & Johnson
MUKESH GORI, Associate Director - ESP Management PV, Operations, Novartis
VAIBHAV KULKARNI, Director - Regulatory Affairs, Abbott Nutrition
SACHIN MANGALVEDHEKAR, Vice President and Head- Clinical and PV QA, Glenmark
FATIMA YOUSEF GHETHAN, Quality Culture & Implementation Manager, Executive Administration of Quality & Patient Safety, Makkah Healthcare Cluster (UAE)
ANUJA JAWALE, Associate Director RA and PV Strategic Sourcing and Vendor Management, Organon
RAJESH RAJENDRAN, Director - Projects and Vendor Management Lead, Worldwide Safety, Pfizer
ANJU AGARWAL, Director Global Patient Safety, Advanz Pharma
VIPIN SETHI, Global Head – Pharmacovigilance, Head – Medical Affairs – ISBU, Cadila
UJWALA NAIK, Country Safety Head, Johnson & Johnson
MILIND ANTANI, Leader - Pharma and Healthcare, Nishith Desai Associates
GEETA SHANBHAG, Vice President - Pharmacovigilance and Medico-regulatory Affairs, Ipca Laboratories
RISHI JAIN, Director Medical Affairs, Medical Information and Pharmacovigilance, AbbVie
DILIP PAWAR, Global Head – Medical Affairs and Pharmacovigilance, Unichem Laboratories
JAMAL BAIG, Multi Country Safety Head, Sanofi
HARSHA K RAJASIMHA, CEO & Founder, Jeeva Informatics Solutions
VALLABH DESHPANDE, Head of Global PV Operations, Glenmark
SIVA KUMAR BUDDHA, Global Phv Surveillance Physician Sr Manager, Teva
VRUNDA PANDYA, Deputy General Manager – Quality Assurance, SPARC
SADANAND KULKARNI, Head-Medical, Regulatory, Vigilance, Quality, Fresenius Kabi
RAJENDRA KUMAR KASI, Head - Global Pharmacovigilance, Zydus Group
VARSHA KHATRY, Head Medical and Scientific Affairs, Quality, and Regulatory, Roche
INDU NAMBIAR, Local Patient Safety Lead, Boehringer Ingelheim
WASIMUZZAMA KHAN, India QPPV (PvOI) & Sr. SDEA Specialis, Haleon
VISHWAS SOVANI, Founder Director, Pharmawisdom
PRASHANT BODHE, Director, CliniSearch
KAVYA KADAM, Consultant Global Clinical Trials
TARUN BISWAS, Manager – Quality and Compliance, (Pharmacovigilance), Ipca Laboratories

Plus more joining soon

SPONSORS

EXHIBITOR - GSS Pharma Services

REGISTRATION DETAILS

Early Bird Price (Valid Until 26th September 2022)
Cost per delegate - Fee: INR 10,000 + GST (18%)

Standard Price (From 27th September 2022)
Cost per delegate - Fee - INR 15,000 + GST (18%)

Conference Sponsor, Exhibition Stall & Paid Speaker Slot – Please revert back to this email with your interest and requirement and we will get back to you.

In order to register simply revert back to this email with the below mentioned details

Company Name & Address:
Attendee Name/Names:
Job Title:
Contact Number:
Email Id:
GST Number (If Applicable):

CERTIFICATION

E-Certificate of attendance would be provided to attendees on request, upon completion of the conference.

Should you or your colleagues wish to register please let me know and I can help you with registration.

Fen Castro

Head - Productions

Virtue Insight

Tel (India) + 91 44 42108101

Tel (UK) + 44 20 3509 3779

CONFIDENTIALITY NOTICE

This message and any included attachments are from Virtue Insight and are intended only for the addressee. The information contained in this message is confidential and may constitute inside or non-public information under international, federal, or state securities laws. Unauthorized forwarding, printing, copying, distribution, or use of such information is strictly prohibited and may be unlawful

P.S: You are receiving this email because you have been identified as someone who may be interested in our publications.

If you'd like to know more about how we process your personal information and data, view our privacy policy page at our website.

We have found your mail address through our own efforts on the web search and not through any illegal way. If you find this mail unsolicited, please reply with “UNSUBSCRIBE" in the subject line and we will take care that you do not receive any further promotional mail from our end.